Cargando…

Systematic review of influenza resistance to the neuraminidase inhibitors

BACKGROUND: Antivirals play a critical role in the prevention and the management of influenza. One class of antivirals, neuraminidase inhibitors (NAIs), is effective against all human influenza viruses. Currently there are two NAI drugs which are licensed worldwide: oseltamivir (Tamiflu(®)) and zana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thorlund, Kristian, Awad, Tahany, Boivin, Guy, Thabane, Lehana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123567/ https://www.ncbi.nlm.nih.gov/pubmed/21592407 http://dx.doi.org/10.1186/1471-2334-11-134

Ejemplares similares

Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada
por: Abed, Yacine, et al.
Publicado: (2019)

Evolution of Heterogeneity (I(2)) Estimates and Their 95% Confidence Intervals in Large Meta-Analyses
por: Thorlund, Kristian, et al.
Publicado: (2012)

In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors
por: Fage, Clément, et al.
Publicado: (2018)

Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019)

Modelling heterogeneity variances in multiple treatment comparison meta-analysis – Are informative priors the better solution?
por: Thorlund, Kristian, et al.
Publicado: (2013)

The Value of Neuraminidase Inhibitors for the Prevention and Treatment of Seasonal Influenza: A Systematic Review of Systematic Reviews
por: Michiels, Barbara, et al.
Publicado: (2013)

Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread
por: Handel, Andreas, et al.
Publicado: (2007)

Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
por: Kamali, Amanda, et al.
Publicado: (2013)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis
por: Jefferson, Tom, et al.
Publicado: (2009)

Bacterial Neuraminidase Rescues Influenza Virus Replication from Inhibition by a Neuraminidase Inhibitor
por: Nishikawa, Tomoko, et al.
Publicado: (2012)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

The role of neuraminidase inhibitors in the treatment and prevention of influenza
por: Naem, Shahrour
Publicado: (2001)

Role of Permissive Neuraminidase Mutations in Influenza A/Brisbane/59/2007-like (H1N1) Viruses
por: Abed, Yacine, et al.
Publicado: (2011)

Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses†
por: Oakley, Aaron J., et al.
Publicado: (2010)

Exploring the chemical space of influenza neuraminidase inhibitors
por: Anuwongcharoen, Nuttapat, et al.
Publicado: (2016)

Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore
por: Lee, Vernon J., et al.
Publicado: (2006)

Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials
por: Shun-Shin, Matthew, et al.
Publicado: (2009)

Reduning Injection versus Neuraminidase Inhibitors in the Treatment of Influenza: A Systematic Review and Meta-Analysis
por: Zhao, Guo-zhen, et al.
Publicado: (2022)

Effects of Vaccination and the New Neuraminidase Inhibitor, Laninamivir, on Influenza Infection
por: Mizuno, Takuro, et al.
Publicado: (2014)

Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea
por: Kim, Heui Man, et al.
Publicado: (2020)

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017)

Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010–2015
por: Tewawong, Nipaporn, et al.
Publicado: (2018)

Management of Influenza Virus Infections with Neuraminidase Inhibitors: Detection, Incidence, and Implications of Drug Resistance
por: McKimm-Breschkin, Jennifer L.
Publicado: (2012)

Functional neuraminidase inhibitor resistance motifs in avian influenza A(H5Nx) viruses
por: Bialy, Dagmara, et al.
Publicado: (2020)

Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza
por: Mawatari, Momoko, et al.
Publicado: (2019)

Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS)
por: Roosenhoff, Rueshandra, et al.
Publicado: (2020)

Effectiveness of Neuraminidase Inhibitors for Preventing Staff Absenteeism during Pandemic Influenza
por: Lee, Vernon J., et al.
Publicado: (2007)

Use of Neuraminidase Inhibitors for Rapid Containment of Influenza: A Systematic Review and Meta-Analysis of Individual and Household Transmission Studies
por: Okoli, George N., et al.
Publicado: (2014)

Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity
por: Laborda, Pedro, et al.
Publicado: (2016)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
por: Jefferson, Tom, et al.
Publicado: (2014)

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein
por: Triana-Baltzer, Gallen B., et al.
Publicado: (2009)

Alternative Regimens of Neuraminidase Inhibitors for Therapy of Hospitalized Adults with Influenza: A Systematic Review of Randomized Controlled Trials
por: Tejada, Sofia, et al.
Publicado: (2020)

Structural basis for a class of nanomolar influenza A neuraminidase inhibitors
por: Kerry, Philip S., et al.
Publicado: (2013)

Contribution of Neuraminidase of Influenza Viruses to the Sensitivity to Sera Inhibitors and Reassortment Efficiency
por: Kiseleva, Irina, et al.
Publicado: (2014)

Neuraminidase Inhibitors in Influenza Treatment and Prevention–Is It Time to Call It a Day?
por: Parra-Rojas, César, et al.
Publicado: (2018)

Comparative Dynamics and Distribution of Influenza Drug Resistance Acquisition to Protein M2 and Neuraminidase Inhibitors
por: Garcia, Vanessa, et al.
Publicado: (2014)

Role of neuraminidase inhibitor chemoprophylaxis in controlling nosocomial influenza: an observational study
por: Higa, Futoshi, et al.
Publicado: (2011)

Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility
por: Paradis, Eric G., et al.
Publicado: (2015)

Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases
por: Hashem, Anwar M., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_lt159a9l6ut9e7hnanidr30me5